Biotech Values

[dewophile]

my guess is that it will be
for me enta right now is far more about abt-493 and how the competition fares than v-pak
I think the only thing that can dampen what should be a good AASLD for ENTA is GILD if they come in with strong 6 week data with their 3DAA. weaker than expected GT3 data from their new 2DAA would also be a plus for ENTA if their GT3 is strong